Literature DB >> 10753814

Structures of virus and virus-like particles.

J E Johnson1, W Chiu.   

Abstract

Virus structures continue to be the basis for mechanistic virology and serve as a paradigm for solutions to problems concerning macromolecular assembly and function in general. The use of X-ray crystallography, electron cryomicroscopy and computational and biochemical methods has provided not only details of the structural folds of individual viral components, but also insights into the structural basis of assembly, nucleic acid packaging, particle dynamics and interactions with cellular molecules.

Mesh:

Substances:

Year:  2000        PMID: 10753814     DOI: 10.1016/s0959-440x(00)00073-7

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  30 in total

1.  Structural studies of MS2 bacteriophage virus particle disassembly by nuclear magnetic resonance relaxation measurements.

Authors:  C D Anobom; S C Albuquerque; F P Albernaz; A C Oliveira; J L Silva; D S Peabody; A P Valente; F C L Almeida
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

Review 2.  Cell-free protein synthesis: applications come of age.

Authors:  Erik D Carlson; Rui Gan; C Eric Hodgman; Michael C Jewett
Journal:  Biotechnol Adv       Date:  2011-10-08       Impact factor: 14.227

Review 3.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

4.  The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging.

Authors:  Anna K Overby; Ralf F Pettersson; Etienne P A Neve
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  Biophysical chemistry: unravelling capsid transformations.

Authors:  Masaki Uchida; Trevor Douglas
Journal:  Nat Chem       Date:  2013-06       Impact factor: 24.427

Review 6.  Therapeutic vaccines for chronic diseases: successes and technical challenges.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

7.  Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres.

Authors:  Pavel Plevka; Anthony J Battisti; Jiraphan Junjhon; Dennis C Winkler; Heather A Holdaway; Poonsook Keelapang; Nopporn Sittisombut; Richard J Kuhn; Alasdair C Steven; Michael G Rossmann
Journal:  EMBO Rep       Date:  2011-05-13       Impact factor: 8.807

8.  A plant derived multifunctional tool for nanobiotechnology based on Tomato bushy stunt virus.

Authors:  Simone Grasso; Chiara Lico; Francesca Imperatori; Luca Santi
Journal:  Transgenic Res       Date:  2012-10-30       Impact factor: 2.788

9.  Protection against lethal challenge by Ebola virus-like particles produced in insect cells.

Authors:  Yuliang Sun; Ricardo Carrion; Ling Ye; Zhiyuan Wen; Young-Tae Ro; Kathleen Brasky; Anysha E Ticer; E Ellen Schwegler; Jean L Patterson; Richard W Compans; Chinglai Yang
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

10.  A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge.

Authors:  Robert B Mandell; Ramesh Koukuntla; Laura J K Mogler; Andrea K Carzoli; Alexander N Freiberg; Michael R Holbrook; Brian K Martin; William R Staplin; Nicholas N Vahanian; Charles J Link; Ramon Flick
Journal:  Virology       Date:  2009-11-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.